You have 9 free searches left this month | for more free features.

toll-like receptor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Testicular Torsion and TLR 4 Was Investigated Trial (Toll-like receptor 4)

Completed
  • Testicular Torsion and TLR 4 Was Investigated
  • Toll-like receptor 4
  • (no location specified)
Sep 23, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam University Medical Centre (location VUmc)
Dec 18, 2022

Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

Not yet recruiting
  • Spondylitis
  • Tuberculosis
  • 400 IU
  • +3 more
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
May 11, 2022

HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)

Recruiting
  • HIV Infections
  • HIVIS DNA/MVA-CMDR
  • +2 more
  • Tygerberg Hills, Cape Town, South Africa
    Stellenbosch University
Apr 20, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

Novel Mechanisms and Approaches to Treat Neonatal Sepsis

Recruiting
  • Complication of Prematurity
  • Immunologic Deficiency Syndromes
  • Adjuvant
  • Blood Collection
  • Gainesville, Florida
    UF Health
Nov 4, 2021

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

Completed
  • Breast Cancer
  • +2 more
  • Radiation
  • +2 more
  • New York, New York
    New York University Medical Center
Oct 25, 2021

The Effect of Human Prostate Tissue on Platelet Activation

Completed
  • Prostate Hyperplasia
  • +2 more
    • (no location specified)
    Sep 19, 2021

    Itch Trial in Aalborg (Zyclara 3.75 % Topical Cream, Prudoxin, Histamine)

    Withdrawn
    • Itch
    • Zyclara 3.75 % Topical Cream
    • +5 more
    • Aalborg, Nordjylland, Denmark
      Aalborg University
    Jan 13, 2021

    Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • +2 more
    • Nivolumab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Dec 16, 2021

    Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • +10 more
    • Atlanta, Georgia
    • +6 more
    Mar 1, 2022

    Tumors or Premalignant Lesions Trial in Leiden (Hespecta)

    Completed
    • Tumors or Premalignant Lesions
    • Hespecta
    • Leiden, Netherlands
      Leiden University Medical Center
    Feb 17, 2021

    Cancer, Tumors Trial in Berlin (GSK1795091, Placebo)

    Completed
    • Cancer
    • Neoplasms
    • Berlin, Germany
      GSK Investigational Site
    Nov 13, 2020

    Glioblastoma, Glioma Trial in New York (Bevacizumab, Peptide Vaccine, Poly-ICLC as immune adjuvant)

    Withdrawn
    • Glioblastoma
    • Glioma
    • New York, New York
      NYU Perlmutter Cancer Center
    Jan 8, 2020

    Glucagon-like Peptide-1 Receptor Agonists According to Type 2

    Recruiting
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Bari, Italy
      Azienda Ospedaliero-Universitaria Policlinico Bari
    Nov 4, 2023

    Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

    Not yet recruiting
    • Overweight and Obesity
    • 24-hour ambulatory blood pressure
    • Liberal salt diet
    • (no location specified)
    Oct 4, 2023

    Preoperative Prandial State of Patients Taking Glucagon-Like

    Recruiting
    • Pulmonary Aspiration
    • Gastric ultrasound
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Jun 6, 2023

    Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

    Recruiting
    • Stroke
    • +3 more
    • Linyi, Shangdong, China
    • +1 more
    Jun 24, 2023

    Glucagon-like Peptide 1 Receptor Agonists and Mental Health

    Not yet recruiting
    • Diabetes Mellitus
    • +2 more
    • GLP-1 receptor agonist
    • (no location specified)
    Aug 4, 2022

    Periodontal Inflammation Trial in Ajman (saliva analysis for Toll like receptor activity)

    Completed
    • Periodontal Inflammation
    • saliva analysis for Toll like receptor activity
    • Ajman, Dubai, United Arab Emirates
      Ajman University
    Dec 16, 2019

    Lymphomas Non-Hodgkin's B-Cell, Diffuse Large B-cell Lymphoma (DLBCL), Primary Mediastinal B-cell Lymphoma (PMBCL) Trial in

    Recruiting
    • Lymphomas Non-Hodgkin's B-Cell
    • +5 more
    • WZTL002-1 (1928T2z CAR-T cells)
    • Cyclophosphamide and Fludarabine lymphodepleting chemotherapy
    • Wellington, New Zealand
      Wellington Hospital, Capital & Coast District Health Board
    Feb 18, 2020